CBIH OTC
Cannabis Bioscience International Holdings, Inc.
1W: +33.3%
1M: +100.0%
3M: -33.3%
YTD: -63.6%
1Y: -60.0%
3Y: -50.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$303K
+21.8% ▲
5Y CAGR: -12.2%
Gross Profit
$263K
+29.4% ▲
5Y CAGR: -14.6%
Operating Income
-$421K
+13.3% ▲
Net Income
-$549K
+15.7% ▲
EPS (Diluted)
$-0.05
+18.9% ▲
EBITDA
-$336K
+32.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $762K | $215K | $317K | $249K | $303K |
| YoY Growth | +31.3% | -71.8% | +47.4% | -21.5% | +21.8% |
| Cost of Revenue | $4K | $47K | $93K | $46K | $40K |
| Gross Profit | $758K | $168K | $223K | $203K | $263K |
| Gross Margin | 99.5% | 78.2% | 70.5% | 81.7% | 86.8% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $873K | $1M | $1M | $649K | $419K |
| Operating Expenses | $873K | $1M | $1M | $689K | $684K |
| Operating Income | -$115K | -$888K | -$983K | -$486K | -$421K |
| Operating Margin | -15.1% | -413.1% | -310.4% | -195.4% | -139.1% |
| Interest Expense | $44K | $51K | $91K | $165K | $180K |
| Income Before Tax | -$159K | -$885K | -$1M | -$651K | -$549K |
| Tax Expense | $0 | $0 | -$36K | $0 | $0 |
| Net Income | -$159K | -$885K | -$1M | -$651K | -$549K |
| Net Margin | -20.9% | -411.7% | -325.9% | -261.8% | -181.1% |
| EPS (Diluted) | $-0.02 | $-0.11 | $-0.10 | $-0.06 | $-0.05 |
| EBITDA | -$111K | -$834K | -$905K | -$497K | -$336K |
| Shares Outstanding | 8M | 8M | 10M | 10M | 11M |